Abstract
Tanshinone IIA (Tan IIA) is a major active ingredient extracted from Salvia miltiorrhiza, which has been proved to be able to inhibit metastasis of various cancers including colorectal cancer (CRC). However, the mechanisms of anti-metastatic effect of Tan IIA on CRC are not well explored. A number of studies indicate that epithelial-to-mesenchymal transition (EMT) plays an important role in CRC metastasis, and our previous studies demonstrate that β-arrestin1could regulate EMT in CRC partly through β-catenin signaling pathway. In this work, we investigate whether Tan IIA could regulate EMT in CRC through β-arrestin1-mediated β-catenin signaling pathway both in vivo and in vitro. Our results showed that Tan IIA inhibited lung metastases of CRC cells in vivo and extended the survival time of mice with CRC. In vitro, Tan IIA increased the expression of E-cadherin, decreased the expression of Snail, N-cadherin and Vimentin, thus suppressed EMT and the migratory ability of CRC cells. Further study found that the mechanism of action of Tan IIA in regulating EMT and metastasis is associated with the suppression of β-arrestin1 expression, resulting in the increase of GSK-3β expression, reduction of β-catenin nuclear localization, there...Continue Reading
References
Nov 4, 2006·Cell·Hans Clevers
Mar 6, 2007·Vascular Pharmacology·Futian TangPeiqing Liu
May 18, 2007·Nature Reviews. Cancer·Héctor PeinadoAmparo Cano
May 13, 2008·Oncogene·V StemmerJ Behrens
Aug 22, 2009·Human Pathology·Marcello GuarinoManuela Nebuloni
Dec 8, 2009·Cancer Science·Masaaki IwatsukiMasaki Mori
Dec 23, 2009·Cancer Biotherapy & Radiopharmaceuticals·Xiaorong DongGang Wu
Mar 30, 2012·BMC Cancer·Patricia González-ArriagaAdonina Tardón
Sep 24, 2013·JAK-STAT·Petr Vaňhara, Karel Souček
Jan 1, 2014·Cancer Letters·Ting YuKathy Qian Luo
Mar 22, 2016·Experimental and Therapeutic Medicine·Yangqiu BaiYuxiu Yang
Jun 15, 2016·Annual Review of Cell and Developmental Biology·Laralynne PrzybylaValerie M Weaver
Sep 14, 2016·Biochemical and Biophysical Research Communications·Xiaolu DuanGuohua Zeng
Nov 18, 2016·Pathology Oncology Research : POR·Bijayatha ShresthaRaghu Radhakrishnan
Feb 1, 2017·Molecular Cancer·Heming LiYunpeng Liu
Mar 3, 2017·Cancer Research·Vivek Kumar MishraSteven A Johnsen
Mar 17, 2017·Cell Death & Disease·Xin TanWenlin Huang
Jun 13, 2017·Cancer Letters·Hua SuiQi Li
Sep 12, 2017·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Masaya NagaishiAkio Hyodo
Dec 21, 2017·Cancers·Trung Vu, Pran K Datta
Jun 7, 2018·NPJ Precision Oncology·Woo-Jeong JeongKang-Yell Choi
Jun 27, 2018·The Journal of Pharmacy and Pharmacology·Nan LiSuqin Chen
Jul 17, 2018·Life Sciences·Yu ZhangChangli Wang
Jul 27, 2018·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Heyuan WangBing Wu
Sep 13, 2018·CA: a Cancer Journal for Clinicians·Freddie BrayAhmedin Jemal
Sep 15, 2018·Experimental and Therapeutic Medicine·Yongjun ZhangTiansheng Cao
Oct 31, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Jun QianJiege Huo
Aug 17, 2019·Journal of Cancer·Liguang WangJiajun Du
Apr 24, 2020·Oncology Reports·Lihong ZhouYan Li